J Berenguer, MC Allende, JW Lee, K Garrett, C Lyman, NM Ali, J Bacher, PA Pizzo and TJ Walsh
Infectious Diseases Section, National Cancer Institute, Bethesda, MD 20892, USA.

Patients with chemotherapy-induced granulocytopenia for neoplastic diseases and those receiving cyclosporin A plus corticosteroids for prevention and treatment of organ transplant rejection are two immunologically distinct patient populations with high risks for development of invasive pulmonary aspergillosis. In order to compare the pathogenesis of aspergillosis in these two high-risk populations and to further characterize the role of cyclosporin A in development of pulmonary aspergillosis, we studied the patterns of infection and inflammation in two clinically applicable rabbit models of invasive pulmonary aspergillosis. There were striking differences in the patterns of infection and inflammation of invasive pulmonary aspergillosis according to the type of underlying immune defect. Among rabbits challenged with the same intratracheal inoculum, there was a 100% mortality for invasive pulmonary aspergillosis in profoundly granulocytopenic rabbits in comparison with a 100% mortality for invasive pulmonary aspergillosis in profoundly granulocytopenic rabbits in comparison with a 100% survival in rabbits immunosuppressed with cyclosporin A plus methylprednisolone (CsA+MP). Lesions of pulmonary aspergillosis in granulocytopenic rabbits consisted predominantly of coagulative necrosis, intraalveolar hemorrhage, and scant mononuclear inflammatory infiltrate. By comparison, pulmonary foci in rabbits immunosuppressed by CsA+MP consisted mainly of neutrophilic and monocytic infiltrates, inflammatory necrosis, and scant intraalveolar hemorrhage. There was extensive infiltration by hyphae with angioinvasion in granulocytopenic rabbits, whereas conidia in various stages of germination predominated in CsA+MP treated animals in which there was a paucity of hyphae or angioinvasion. Extrapulmonary disease predominated in granulocytopenic rabbits. Methylprednisolone was the major immunosuppressive drug in rabbits treated with CsA+MP. Cyclosporin A alone did not increase the progression of pulmonary aspergillosis and did so only when used chronically with methylprednisolone.

This article has been cited by other articles:

				P. Bulpa, A. Dive, and Y. Sibille Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease Eur. Respir. J., October 1, 2007; 30(4): 782 - 800. [Abstract] [Full Text] [PDF]

				R. E. Lewis, G. Chamilos, R. A. Prince, and D. P. Kontoyiannis Pretreatment with Empty Liposomes Attenuates the Immunopathology of Invasive Pulmonary Aspergillosis in Corticosteroid-Immunosuppressed Mice Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1078 - 1081. [Abstract] [Full Text] [PDF]

				C. G. Dennis, W. R. Greco, Y. Brun, R. Youn, H. K. Slocum, R. J. Bernacki, R. Lewis, N. Wiederhold, S. M. Holland, R. Petraitiene, et al. Effect of Amphotericin B and Micafungin Combination on Survival, Histopathology, and Fungal Burden in Experimental Aspergillosis in the p47phox-/- Mouse Model of Chronic Granulomatous Disease Antimicrob. Agents Chemother., February 1, 2006; 50(2): 422 - 427. [Abstract] [Full Text] [PDF]

				S. D. Stephens-Romero, A. J. Mednick, and M. Feldmesser The Pathogenesis of Fatal Outcome in Murine Pulmonary Aspergillosis Depends on the Neutrophil Depletion Strategy Infect. Immun., January 1, 2005; 73(1): 114 - 125. [Abstract] [Full Text] [PDF]

				B. Musher, D. Fredricks, W. Leisenring, S. A. Balajee, C. Smith, and K. A. Marr Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid J. Clin. Microbiol., December 1, 2004; 42(12): 5517 - 5522. [Abstract] [Full Text] [PDF]

				G.-C. Chang, C.-L. Wu, S.-H. Pan, T.-Y. Yang, C.-S. Chin, Y.-C. Yang, and C.-D. Chiang The Diagnosis of Pneumonia in Renal Transplant Recipients Using Invasive and Noninvasive Procedures Chest, February 1, 2004; 125(2): 541 - 547. [Abstract] [Full Text] [PDF]

				C. E. O'Sullivan, M. Kasai, A. Francesconi, V. Petraitis, R. Petraitiene, A. M. Kelaher, A. A. Sarafandi, and T. J. Walsh Development and Validation of a Quantitative Real-Time PCR Assay Using Fluorescence Resonance Energy Transfer Technology for Detection of Aspergillus fumigatus in Experimental Invasive Pulmonary Aspergillosis J. Clin. Microbiol., December 1, 2003; 41(12): 5676 - 5682. [Abstract] [Full Text] [PDF]

				M. J. Becker, S. de Marie, M. H. A. M. Fens, H. A. Verbrugh, and I. A. J. M. Bakker-Woudenberg Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis J. Antimicrob. Chemother., September 1, 2003; 52(3): 428 - 434. [Abstract] [Full Text] [PDF]

				C. Agusti, A. Rano, X. Filella, J. Gonzalez, A. Moreno, A. Xaubet, and A. Torres Pulmonary Infiltrates in Patients Receiving Long-term Glucocorticoid Treatment: Etiology, Prognostic Factors, and Associated Inflammatory Response Chest, February 1, 2003; 123(2): 488 - 498. [Abstract] [Full Text] [PDF]

				J.M. Habicht, M. Preiss, J. Passweg, P. Dalquen, P. Matt, H. Adler, R. Frei, and H.-R. Zerkowski Invasive pulmonary aspergillosis: effects of early resection in a neutropenic rat model Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 728 - 732. [Abstract] [Full Text] [PDF]

				D. R. Nunley, A. A. Gal, J. D. Vega, C. Perlino, P. Smith, and E. C. Lawrence Saprophytic Fungal Infections and Complications Involving the Bronchial Anastomosis Following Human Lung Transplantation Chest, October 1, 2002; 122(4): 1185 - 1191. [Abstract] [Full Text] [PDF]

				T Angelotti, G Krishna, J Scott, G Berry, and A Weinacker Nodular invasive tracheobronchitis due to Aspergillus in a patient with systemic lupus erythematosus Lupus, May 1, 2002; 11(5): 325 - 328. [Abstract] [PDF]

				S. P. Kloska, K. Ludwig, M. Kreuter, R. Diallo, and W. Heindel Aspergilloma of the Breast in a Woman with Acute Myeloid Leukemia Am. J. Roentgenol., May 1, 2002; 178(5): 1236 - 1238. [Full Text] [PDF]

				R. Petraitiene, V. Petraitis, A. H. Groll, T. Sein, R. L. Schaufele, A. Francesconi, J. Bacher, N. A. Avila, and T. J. Walsh Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia Antimicrob. Agents Chemother., January 1, 2002; 46(1): 12 - 23. [Abstract] [Full Text] [PDF]

				R. Crameri and K. Blaser Allergy and immunity to fungal infections and colonization Eur. Respir. J., January 1, 2002; 19(1): 151 - 157. [Abstract] [Full Text] [PDF]

				J. K. Brieland, C. Jackson, F. Menzel, D. Loebenberg, A. Cacciapuoti, J. Halpern, S. Hurst, T. Muchamuel, R. Debets, R. Kastelein, et al. Cytokine Networking in Lungs of Immunocompetent Mice in Response to Inhaled Aspergillus fumigatus Infect. Immun., March 1, 2001; 69(3): 1554 - 1560. [Abstract] [Full Text] [PDF]

				L.P. Nicod, J-C. Pache, and N. Howarth Fungal infections in transplant recipients Eur. Respir. J., January 1, 2001; 17(1): 133 - 140. [Abstract] [Full Text] [PDF]

				F. Reichenberger, J.M. Habicht, A. Gratwohl, and M. Tamm Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients Eur. Respir. J., January 1, 2001; 19(4): 743 - 755. [Abstract] [Full Text] [PDF]

				C. C. Leutner, J. Gieseke, G. Lutterbey, C. K. Kuhl, A. Glasmacher, E. Wardelmann, A. Theisen, and H. H. Schild MR Imaging of Pneumonia in Immunocompromised Patients: Comparison with Helical CT Am. J. Roentgenol., August 1, 2000; 175(2): 391 - 397. [Abstract] [Full Text] [PDF]

				J. M. Habicht, F. Reichenberger, A. Gratwohl, H.-R. Zerkowski, and M. Tamm Surgical aspects of resection for suspected invasive pulmonary fungal infection in neutropenic patients Ann. Thorac. Surg., August 1, 1999; 68(2): 321 - 325. [Abstract] [Full Text] [PDF]

				J.-P. Latge Aspergillus fumigatus and Aspergillosis Clin. Microbiol. Rev., April 1, 1999; 12(2): 310 - 350. [Abstract] [Full Text] [PDF]

				V. Petraitis, R. Petraitiene, A. H. Groll, A. Bell, D. P. Callender, T. Sein, R. L. Schaufele, C. L. McMillian, J. Bacher, and T. J. Walsh Antifungal Efficacy, Safety, and Single-Dose Pharmacokinetics of LY303366, a Novel Echinocandin B, in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits Antimicrob. Agents Chemother., November 1, 1998; 42(11): 2898 - 2905. [Abstract] [Full Text]

				J. R. Graybill, R. Bocanegra, L. K. Najvar, D. Loebenberg, and M. F. Luther Granulocyte Colony-Stimulating Factor and Azole Antifungal Therapy in Murine Aspergillosis: Role of Immune Suppression Antimicrob. Agents Chemother., October 1, 1998; 42(10): 2467 - 2473. [Abstract] [Full Text]

				F. REICHENBERGER, J. HABICHT, A. KAIM, P. DALQUEN, F. BERNET, R. SCHLAPFER, P. STULZ, A. P. PERRUCHOUD, A. TICHELLI, A. GRATWOHL, et al. Lung Resection for Invasive Pulmonary Aspergillosis in Neutropenic Patients with Hematologic Diseases Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 885 - 890. [Abstract] [Full Text] [PDF]